TPI claim new local plant will reduce cost of ARVs in the region
Tanzanian Pharmaceutical Industries (TPI) is set to open the doors to a new anti-retroviral drugs (ARVs) manufacturing plant.
Tanzanian Pharmaceutical Industries (TPI) is set to open the doors to a new anti-retroviral drugs (ARVs) manufacturing plant.
update
Chemicals maker Granules India says it will expand manufacturing capacity for oral solid dose (OSD) APIs and drug intermediates in a bid to better meet the needs of clients.
inVentiv Health says European communications group’s new ‘super agency’ structure will help it to compete in a market dominated by large multi-nationals.
Batavia Bioservices has gained access to simulated moving bed (SMB) technology by collaborating with Xendo.
in-PharmaTechnologist presents a roundup of the latest drug delivery research, including bone marrow targeting nanoparticles and an imaging-treatment combo.
Big public CROs now generate more than half their collective revenue outside the US after triple-digit growth in recent years, a report found.